Merck & Co., Inc.MRK

Market cap
$292.3B
P/E ratio
800.8x
Dec 31,
2011
Dec 31,
2012
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Sales48,04747,26744,03342,23739,49839,80740,12242,29446,84047,99448,70459,28360,115
Cost of sales-------13,50914,11215,48513,62617,41116,126
Selling, general and administrative13,73312,77611,91111,60610,3139,7629,83010,10210,61510,4689,63410,04210,504
Research and development8,4678,1687,5037,1806,70410,12410,2089,7529,87213,55812,24513,54830,531
Restructuring costs1,3066641,7091,013619651776632638578661337599
Other (income) expense, net-946-1,116-81511,356-1,527-720-12402-1398861,341-1,501-466
Total costs, expenses and other40,71338,52838,48824,95434,09735,14833,60133,59335,37639,20334,82542,83958,226
Income from Continuing Operations Before Taxes7,3348,7395,54517,2835,4014,6596,5218,70111,4648,79113,87916,4441,889
Income Tax Expense (Benefit)9422,4401,0285,3499427184,1032,5081,6871,7091,5211,9181,512
Net Income from Continuing Operations----------12,35814,526377
Less: Net Income Attributable to Noncontrolling Interests----------13712
Net Income from Continuing Operations Attributable to Merck & Co., Inc.----------12,34514,519365
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent----------704--
Net Income Attributable to Merck & Co., Inc.6,3926,2994,51711,9344,4593,9412,4186,2209,8437,08213,04914,519365
Income from Continuing Operations (in dollars per share)----------4.885.730.14
Income from Discontinued Operations (in dollars per share)----------0.28--
Net Income (in dollars per share)2.042.031.494.121.581.420.882.343.842.795.165.730.14
Income from Continuing Operations (in dollars per share)----------4.865.710.14
Income from Discontinued Operations (in dollars per share)----------0.28--
Net Income (in dollars per share)2.0221.474.071.561.410.872.323.812.785.145.710.14